New York University

About: New York University is a education organization based out in New York, New York, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 72380 authors who have published 165545 publications receiving 8334030 citations. The organization is also known as: NYU & University of the City of New York.

Statistical Power Analysis

Abstract: pression, Journal of Clinical Psychiatry, 51, 61-69 (1990). 11. L.R. Baxter, Jr., J.M. Schwartz, B.H. Guze, J.C. Mazziotta, M.P. Szuba, K. Bergman, A. Alazraki, C.E. Selin, H.K. Freng, P. Munford, and M.E. Phelps, Obsessive-compulsive disorder vs. Tourette's disorder: Differential function in subdivi sions of the neostriatum, paper presented at the an nual meeting of the American College of Neuropsy chopharmacology, San Juan, Puerto Rico (December 1991). 12. E.M. Reiman, M.E. Raichle, F.K. Butler, P. Herscovitch, and E. Robins, A focal brain abnormal ity in panic disorder, a severe form of anxiety, Na ture, 310, 683-685 (1984); E.M. Reiman, M.E. Ra ichle, E. Robins, F.K. Butler, P. Herscovitch, P. Fox, and J. Perlmutter, The application of positron emis sion tomography to the study of panic disorder, American Journal of Psychiatry, 143, 469-477 (1986); T.E. Nordahl, W.E. Semple, M. Gross, T.A. Mellman, M.B. Stein, P. Goyer, A.C. King, T.W. Uhde, and R.M. Cohen, Cerebral glucose metabolic differences in patients with panic disorder, Neuro psychopharmacology, 3, 261-272 (1990).

The Financial Accelerator in a Quantitative Business Cycle Framework

Abstract: This paper develops a dynamic general equilibrium model that is intended to help clarify the role of credit market frictions in business fluctuations, from both a qualitative and a quantitative standpoint. The model is a synthesis of the leading approaches in the literature. In particular, the framework exhibits a financial accelerator,' in that endogenous developments in credit markets work to amplify and propagate shocks to the macroeconomy. In addition, we add several features to the model that are designed to enhance the empirical relevance. First, we incorporate money and price stickiness, which allows us to study how credit market frictions may influence the transmission of monetary policy. In addition, we allow for lags in investment which enables the model to generate both hump-shaped output dynamics and a lead-lag relation between asset prices and investment, as is consistent with the data. Finally, we allow for heterogeneity among firms to capture the fact that borrowers have differential access to capital markets. Under reasonable parametrizations of the model, the financial accelerator has a significant influence on business cycle dynamics.

Illiquidity and Stock Returns: Cross-Section and Time-Series Effects

Abstract: New tests are presented on the effects of stock illiquidity on stock return. Over time, expected market illiquidity positively affects ex ante stock excess return (usually called â¬Srisk premiumâ¬?). This complements the positive cross-sectional return-illiquidity relationship. The illiquidity measure here is the average daily ratio of absolute stock return to dollar volume, which is easily obtained from daily stock data for long time series in most stock markets. Illiquidity affects more strongly small firms stocks, suggesting an explanation for the changes â¬Ssmall firm effectâ¬? over time. The impact of market illiquidity on stock excess return suggests the existence of illiquidity premium and helps explain the equity premium puzzle.

The Cholinergic Hypothesis of Geriatric Memory Dysfunction

Abstract: Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed. An attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature. Significant cholinergic dysfunctions occur in the aged and demented central nervous system, relationships between these changes and loss of memory exist, similar memory deficits can be artificially induced by blocking cholinergic mechanisms in young subjects, and under certain tightly controlled conditions reliable memory improvements in aged subjects can be achieved after cholinergic stimulation. Conventional attempts to reduce memory impairments in clinical trials hav not been therapeutically successful, however. Possible explanations for these disappointments are given and directions for future laboratory and clinical studies are suggested.